(1)
Li, C.; Yang, Z.; Xie, J.; Long, Y. A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants: Serum CA-125, HE4, microRNA-200a, and Interleukin- Serous Ovarian Carcinoma. J Med Biochem 2026. https://doi.org/10.5937/jomb0-65630.